The Impact of Congress Abstracts on Overall Publications in Acute Myeloid Leukemia (AML): Results of a Systematic Literature Review

Author(s)

Moreau A, Richard ME, Harricharan S, Forsythe A
Cytel Inc., Waltham, MA, USA

Presentation Documents

OBJECTIVES: Traditional systematic literature reviews (SLRs) mainly consist of indexed publications and are rarely updated, primarily relying on full-text articles to support findings. Within rapidly evolving therapeutic areas such as acute myeloid leukemia (AML), congress abstracts can represent an expedient route to disseminate preliminary or updated trial results, as well as real-world datasets. This study aimed to describe recent trends in congress abstract publications within AML.

METHODS: An SLR was performed using pre-defined search terms in accordance with PRISMA guidelines. EMBASE, MEDLINE, and Cochrane databases were systematically searched from 01/2019 to 12/2020 to identify interventional and real-world evidence (RWE) studies presented at congresses describing efficacy and safety, and studies reporting health-related quality of life (HRQoL) and economic outcomes in AML. All selected congress abstracts were extracted and categorized using the PubTracker™ platform.

RESULTS: Of 4312 total citations published within AML in the past two years, a total of 622 (14.4%) were congress abstracts, most frequently presented at ASH (33.3%), EHA (21.2%), EBMT (11.7%), SOHO (8.5%), TCT (4.8%), ISPOR (4.34%), ASCO (3.9%), BSH (2.57%), SIE (1.8%), and other congresses (7.88%). Three times as many abstracts were published in 2019 (75.08%) compared to 2020 (24.92 %), likely due to the COVID-19 pandemic, where congresses were either cancelled or shifted to “virtual meetings”. Within the selected publications, most (63.5%) were real-world studies or interventional studies (25.9%), reporting efficacy and/or safety outcomes. 6.4% and 4.2% of congress abstracts reported economic and HRQoL outcomes, respectively. Studies were mainly conducted in the United States (39.39%), and 5.31% were multi-national.

CONCLUSIONS: Congress abstracts are an important source of evidence within the dynamic landscape of AML, notably in the real-world setting. Almost half of all identified congress abstracts within AML were presented at ASH, EHA, and EBMT, demonstrating the need for these congresses to be actively monitored.

Conference/Value in Health Info

2021-11, ISPOR Europe 2021, Copenhagen, Denmark

Value in Health, Volume 24, Issue 12, S2 (December 2021)

Code

POSC422

Topic

Economic Evaluation, Real World Data & Information Systems

Topic Subcategory

Distributed Data & Research Networks, Value of Information

Disease

Oncology

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×